Medical Malpractice

Medical providers have advanced education and training, but, unfortunately, they sometimes make errors in their diagnosis or treatment – and their mistakes are sometimes deadly.

Request Malpractice Consultation

Surgical errors, birth injuries, misdiagnoses, failure to make a timely diagnosis . . . all of these medical mistakes by physicians and other healthcare providers can leave patients with lasting debilities and huge medical expenses. Personal injury attorneys seek compensation for people who have been injured by someone else’s negligence or recklessness. This includes filing medical malpractice lawsuits against doctors, nurses, lab techs, clinicians, and others in the healthcare field who have failed to provide a reasonable standard of care. Such litigation requires skilled investigation and the testimony of medical experts and is often handled on a contingency fee basis because of the high costs associated with such an action. For that same reason, defendant doctors and their insurance companies often seek resolution through settlement before the trial commences.

Personal Injury News from the PBM Blog


Zofran, a GlaxoSmith Kline drug developed to treat nausea in those receiving cancer treatments, has become one of the top 20 brand-name drugs in the U.S. It has undoubtedly helped millions of cancer patients endure the side effects of radiation and chemotherapy and surgical patients ward off post-operative nausea. However, over the years it has […]

Philadelphia Risperdal Litigation Underway   |   January 30th, 2015

The first Risperdal trial is well underway in the Philadelphia Common Pleas Court.  The trial is focused on how Risperdal, an antipsychotic drug originally only approved for schizophrenia and bipolar disorder in adults, was used by its manufacturer, to target  young children for the treatment of autism, mental illness and behavioral issues and the manufacturer’s […]

GlaxoSmithKline Plc (GSK)’s anti-seizure drug Potiga now carries a black-box warning in the U.S. on risks including potential vision loss.   |   November 1st, 2013

The warning, the most serious type the U.S. Food and Drug Administration issues, underscores risks of abnormalities in the eye, vision loss and skin discoloration, all of which may become permanent, the FDA said in a statement today. The revised label comes after the risks were flagged by the FDA in April. Patients should have […]